Product Information
TADALAFIL 20 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.2051 per EA under NDC 75834025030. Its NADAC has been published 197 times since Jun 2, 2021.
FDA first approved this application on Oct 23, 2020. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834025030
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA211298FDA Approved
10/23/2020
TE Code
AB1
On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 20 MG TABLET has been published 197 times since Jun 2, 2021, and over the history we have for it it has declined 61.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2051 per EA |
|---|---|
| All-time high | $0.5342 (Jun 16, 2021) |
| All-time low | $0.1568 (Nov 20, 2024) |
| Median price | $0.3165 |
| Average price | $0.3234 |
| Largest weekly change | +57.2% (Sep 21, 2022) |
| Weeks tracked | 197 |
| Tracking since | Jun 2, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-35.4%
5Y
-53.2%
All
-61.6%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 18 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.2051 per EA (NDC 75834025030), effective Mar 5, 2025.
How has the price of TADALAFIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 61.6%. It has been tracked across 197 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?
Since Jun 2, 2021, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1568 (Nov 20, 2024) to a high of $0.5342 (Jun 16, 2021), with a median of $0.3165 per EA.
Are there cheaper alternatives to TADALAFIL 20 MG TABLET?
Yes. 18 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYQ 20 MG TABLET, is $0.1400 per EA — about 32% below TADALAFIL 20 MG TABLET.
Who manufactures TADALAFIL 20 MG TABLET?
TADALAFIL 20 MG TABLET (NDC 75834025030) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.